PharmTech Drug Digest 11.20
News|Articles|June 7, 2016

Troubleshooting in Tablet Tooling Seminar

 

As part of I Holland's customer service programme, the company will be holding its popular seminar 'Troubleshooting in Tablet Tooling' on 23rd and 24th June 2016. The seminar is designed to address common issues encountered during modern tablet production and looks at how elements of punch and die design, tooling specification and maintenance can have an impact on tablet press performance. The course is interactive and includes a series of workshops, as well as a full factory tour, where delegates can see punch manufacture from design through to despatch of the final product. The course has been developed based on I Holland's 70 years' experience in the tabletting industry and is designed to give an in-depth technical view on troubleshooting from a tablet manufacturer's perspective. The course is designed for anyone involved in tablet production or tooling maintenance.

 

Further details can be found at the following link: http://tablettingscience.com/PDFs/Downloads/seminar---troubleshooting-in-tablet-tooling.pdf

 

Contact Details :

I Holland Limited

Website: www.iholland.co.uk

E-mail: info@iholland.co.uk

 


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.